…
Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Public information on Avenir Wellness Solutions Inc. (AVRW.US), an OTC-listed issuer, is limited and the company's core operations are not clearly described in widely available filings. Because verified disclosure is scarce, long-term growth drivers are unclear and would depend on management's strategy and execution; investors may find the stock of interest only after reviewing filings or credible operational details.
Material risks include scant disclosure and transparency, low trading liquidity, potential lack of revenue or profitability, high financing and dilution risk, and heightened regulatory and operational uncertainty common among pink-sheet issuers.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Income before tax | -3.44M | -18.50M | -13.19M | -30.62M | -21.37M |
| Minority interest | - | - | - | 0.00M | 0.01M |
| Net income | -3.44M | -25.51M | -13.19M | -30.62M | -21.36M |
| Selling general administrative | 6.25M | 10.17M | 18.88M | 11.37M | 10.12M |
| Selling and marketing expenses | 2.81M | - | - | - | - |
| Gross profit | 3.11M | 3.34M | 4.38M | 0.97M | 0.39M |
| Reconciled depreciation | 0.18M | 1.58M | 3.61M | 0.94M | 0.58M |
| Ebit | -3.38M | - | -16.87M | -13.18M | -11.73M |
| Ebitda | -3.20M | -16.45M | -9.03M | -27.21M | -16.68M |
| Depreciation and amortization | 0.18M | - | - | - | - |
| Operating income | -5.51M | -8.39M | -16.87M | -13.18M | -12.04M |
| Other operating expenses | 9.85M | - | - | - | - |
| Interest expense | 0.06M | 0.47M | 0.55M | 2.47M | 4.11M |
| Tax provision | 0.00M | 0.04M | 0.00M | 0.00M | 0.00M |
| Interest income | 0.05M | 0.05M | 0.06M | 0.04M | 0.06M |
| Net interest income | -0.01M | -0.41M | -0.49M | -2.44M | -4.05M |
| Income tax expense | 0.00M | - | - | - | - |
| Total revenue | 4.35M | 4.90M | 6.55M | 2.05M | 0.62M |
| Total operating expenses | 8.62M | 13.28M | 23.42M | 15.23M | 12.66M |
| Cost of revenue | 1.24M | 1.56M | 2.17M | 1.08M | 0.23M |
| Total other income expense net | 2.06M | -9.70M | 4.17M | -15.01M | -5.28M |
| Net income from continuing ops | -3.44M | -18.54M | -13.19M | -30.62M | -21.37M |
| Net income applicable to common shares | - | - | -13.19M | -30.62M | -21.36M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 2.61M | 6.85M | 40.57M | 46.36M | 32.46M |
| Intangible assets | 0.30M | 0.32M | 22.29M | 25.61M | 16.10M |
| Other current assets | 0.29M | 0.03M | 0.12M | 0.78M | 1.14M |
| Total liab | 12.49M | 13.96M | 24.46M | 25.08M | 18.95M |
| Total stockholder equity | -9.89M | -7.11M | 16.11M | 21.28M | 13.51M |
| Other current liab | 1.01M | 0.86M | 4.39M | 2.03M | 9.62M |
| Common stock | 0.08M | - | 0.07M | 0.06M | 0.04M |
| Capital stock | 0.08M | 0.07M | 0.07M | 0.06M | 0.04M |
| Retained earnings | -123.40M | -119.95M | -94.45M | -81.25M | -50.63M |
| Other liab | - | - | - | 3.29M | 7.07M |
| Good will | - | 0.00M | 13.87M | 13.87M | 9.18M |
| Other assets | - | - | 0.28M | 0.06M | 0.04M |
| Cash | 0.05M | 2.94M | 0.02M | 1.73M | 4.10M |
| Total current liabilities | 12.49M | 13.91M | 24.26M | 14.47M | 11.84M |
| Current deferred revenue | 0.42M | - | - | - | - |
| Net debt | 8.23M | 6.95M | 13.58M | 14.18M | - |
| Short term debt | 8.28M | - | - | - | - |
| Short long term debt | 8.24M | 9.89M | 13.59M | 8.89M | 0.73M |
| Short long term debt total | 8.28M | - | - | - | - |
| Other stockholder equity | 113.44M | - | 0.34M | 0.67M | 1.07M |
| Property plant equipment | - | - | 2.14M | 2.47M | 0.70M |
| Total current assets | 1.96M | 5.93M | 1.78M | 3.85M | 6.19M |
| Long term investments | 0.26M | 0.41M | 0.22M | 0.51M | 0.26M |
| Net tangible assets | - | - | -20.04M | -18.19M | -11.77M |
| Net receivables | 1.42M | 0.23M | 0.36M | 0.22M | 0.14M |
| Long term debt | - | - | - | 7.01M | - |
| Inventory | 0.20M | 0.14M | 0.96M | 0.66M | 0.16M |
| Accounts payable | 2.45M | 1.06M | 2.85M | 2.13M | 1.26M |
| Non currrent assets other | 0.04M | 0.04M | 0.08M | 0.06M | 0.04M |
| Non current assets total | 0.65M | 0.93M | 38.79M | 42.51M | 26.27M |
| Capital lease obligations | 0.04M | 0.17M | 0.32M | 0.42M | 0.06M |
| Breakdown | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Investments | 0.97M | 13.84M | -0.06M | -0.25M | -0.26M |
| Change to liabilities | - | - | 0.26M | -0.93M | 0.30M |
| Total cashflows from investing activities | 0.97M | - | -0.17M | -1.49M | -0.92M |
| Net borrowings | -0.02M | - | 2.78M | 6.06M | 1.57M |
| Total cash from financing activities | -0.02M | -0.84M | 2.78M | 8.84M | 12.61M |
| Change to operating activities | - | - | 3.63M | 0.73M | -1.82M |
| Net income | -3.44M | -25.51M | -13.19M | -30.62M | -21.36M |
| Change in cash | -2.89M | 2.93M | -1.71M | -2.37M | 3.60M |
| Begin period cash flow | 2.94M | 0.02M | 1.73M | 4.10M | 0.50M |
| End period cash flow | 0.05M | 2.94M | 0.02M | 1.73M | 4.10M |
| Total cash from operating activities | -3.84M | -10.07M | -4.32M | -9.72M | -8.10M |
| Issuance of capital stock | - | - | - | 0.00M | 2.50M |
| Depreciation | 0.18M | 1.58M | 3.61M | 0.92M | 0.58M |
| Other cashflows from investing activities | 0.97M | - | - | -0.55M | -0.20M |
| Change to inventory | 0.02M | 0.31M | -0.24M | -0.15M | -0.12M |
| Change to account receivables | -0.21M | 0.16M | -0.17M | -0.06M | -0.03M |
| Other cashflows from financing activities | -0.16M | - | - | - | - |
| Change to netincome | - | - | 1.79M | 18.89M | 13.10M |
| Capital expenditures | 0.05M | 0.00M | 0.04M | 0.67M | 0.41M |
| Change in working capital | 1.28M | 1.72M | 3.48M | -0.43M | -1.67M |
| Stock based compensation | 0.62M | 1.63M | 3.88M | 3.42M | 4.14M |
| Other non cash items | -2.48M | -0.70M | -1.38M | 16.60M | 6.88M |
| Free cash flow | -3.90M | -10.07M | -4.43M | -10.41M | -8.56M |
Sector: Consumer Defensive Industry: Packaged Foods
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AVRW Avenir Wellness Solutions Inc. |
- -% |
0.00 | - | - | 0.01 | - | 4.34 | -1.22 |
| NSRGF Nestle SA |
1.11 1.12% |
100.36 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-0.47 0.47% |
100.36 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| DANOY Danone PK |
-0.08 0.58% |
13.77 | 24.23 | 17.64 | 1.88 | 2.57 | 1.88 | 11.70 |
| GPDNF Danone S.A |
- -% |
69.76 | 20.30 | 14.75 | 1.65 | 2.24 | 1.76 | 10.92 |
Avenir Wellness Solutions, Inc., together with its subsidiary, The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in dosage forms for wellness. The company offers its products in the health, wellness, and beauty sectors under the Seratopical, Seratopical Revolution SeraLabs, and Nutri-Strips brand names. It sells its products to direct-to-consumer through online website orders, including opt-in subscribe and save option, as well as online and in-store at national drug, mass retailers, grocery chains, convenience stores, and on Amazon.com. The company was formerly known as CURE Pharmaceutical Holding Corp. and changed its name to Avenir Wellness Solutions, Inc. in January 2023. Avenir Wellness Solutions, Inc. was incorporated in 2014 and is based in Sherman Oaks, California.
15233 Ventura Boulevard, Sherman Oaks, CA, United States, 91403
424 273 8675
| Name | Title | Year Born |
|---|---|---|
| Mr. Robert Davidson | Founder, Chief Scientist & Chairman of the Board | 1967 |
| Ms. Nancy Duitch | CEO & Director | 1955 |
| Mr. Joel M. Bennett CPA | CFO, Chief Accounting Officer, Secretary & Treasurer | 1962 |
| Ms. Patricia Hess | Chief Operating Officer | NA |
| Mr. Bhaumik Patel | Director of New Technologies | NA |
| Mr. John Cammarano Jr. | Senior Vice President of Sales | 1964 |
| Dr. Rahul Dixit M.D. | Chief Medical Officer & Member of Medical Advisory Board | NA |
| Mr. Rick Petry | Senior VP & Executive Creative Director | NA |
| Mr. Joel M. Bennett CPA | CFO, Chief Accounting Officer, Secretary, Treasurer & Interim CEO | 1962 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.